Trials / Withdrawn
WithdrawnNCT04402515
Tiotropium Plus Olodaterol vs Inhaled Corticosteroids (ICS) Regimens in the Portuguese Primary Care Setting (TIOLCOR Study)
Preferences and Consequences in Therapy Decision-making: Tiotropium Bromide Plus Olodaterol vs ICS-containing Regimens in COPD Patients in the Portuguese Primary Care Setting: an Observational, Cross-sectional Study
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
What are the differences between patients prescribed a new maintenance treatment for Chronic Obstructive Pulmonary Disease (COPD) with tiotropium/olodaterol (TIO/OLO) or Inhaled Corticosteroids (ICS)-containing regimens in terms of sociodemographic, anthropometric and clinical characteristics?
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TIO/OLO | Tiotropium/Olodaterol |
| DRUG | ICS | inhaled cortocosteroids |
Timeline
- Start date
- 2021-10-28
- Primary completion
- 2022-01-15
- Completion
- 2022-01-31
- First posted
- 2020-05-27
- Last updated
- 2021-11-05
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04402515. Inclusion in this directory is not an endorsement.